Pakistan Pharmaceutical Track & Trace System 2026 | DRAP Regulations & GS1 Compliance

Learn about Pakistan's Pharmaceutical Track & Trace System 2026, the latest DRAP regulations, GS1 barcode requirements, serialization, implementation timeline, and their impact on pharmaceutical manufacturers.

--

6/29/20264 min read

Pakistan's pharmaceutical industry is entering a new era of digital supply chain management with the implementation of the Pakistan Pharmaceutical Track & Trace System (PTTS). Introduced by the Drug Regulatory Authority of Pakistan (DRAP), the system aims to eliminate counterfeit medicines, improve patient safety, increase supply chain transparency, and ensure compliance with international pharmaceutical standards.

The latest regulation, S.R.O. 963(I)/2026, published on 9 June 2026, establishes the final framework for serialization, barcode implementation, and pharmaceutical traceability across Pakistan.

This article explains the latest regulations, implementation timeline, GS1 requirements, and how pharmaceutical companies can prepare for compliance.

What is the Pakistan Pharmaceutical Track & Trace System?

The Pakistan Pharmaceutical Track & Trace System (PTTS) is a national pharmaceutical serialization program designed to identify every medicine package with a unique serial number.

Each medicine pack receives a unique digital identity using GS1 global standards, allowing manufacturers, distributors, regulators, pharmacies, and healthcare providers to verify product authenticity throughout the supply chain.

The primary objectives include:

  • Prevent counterfeit medicines

  • Eliminate illegal and smuggled pharmaceuticals

  • Improve patient safety

  • Increase visibility across the pharmaceutical supply chain

  • Strengthen regulatory compliance

  • Enable product recalls more efficiently

Why Pakistan Introduced Pharmaceutical Serialization

Counterfeit medicines remain a major global healthcare challenge. Fake or substandard drugs can lead to treatment failure, patient harm, and financial losses for manufacturers.

To address these risks, DRAP introduced mandatory serialization and barcode requirements aligned with global pharmaceutical traceability standards.

The initiative also supports Pakistan's pharmaceutical exports by aligning local manufacturers with international regulatory expectations.

Evolution of Pakistan's Pharmaceutical Track & Trace Regulations

S.R.O. 470(I)/2017

The first major serialization regulation was introduced on 14 June 2017.

It required pharmaceutical manufacturers to implement:

  • GS1 DataMatrix barcode on secondary packaging

  • GTIN on primary packaging

  • Serialization within two years

  • Full Track & Trace implementation within three years

Although ambitious, the regulation faced significant concerns from the pharmaceutical industry due to technical complexity, production costs, and limited implementation time.

Supreme Court Intervention (2018)

Following several counterfeit medicine incidents, Pakistan's Supreme Court instructed DRAP to revise the regulations after consulting pharmaceutical manufacturers.

The Court requested DRAP to review:

  • Practical implementation timelines

  • Primary packaging barcode requirements

  • Technical feasibility

  • Industry concerns

This consultation resulted in a more practical regulatory framework.

S.R.O. 962(I)/2019

Published on 27 August 2019, this regulation introduced important improvements.

Key changes included:

  • Removal of mandatory serialization on primary packaging

  • Extension of serialization implementation from two years to six years

  • Six-year transition period for SSCC implementation

  • Greater flexibility for pharmaceutical manufacturers

These revisions reduced implementation challenges while maintaining traceability objectives.

Latest Regulation: S.R.O. 963(I)/2026

The newest regulation, S.R.O. 963(I)/2026, published on 9 June 2026, finalizes Pakistan's pharmaceutical serialization framework.

The regulation confirms DRAP's commitment to creating a fully digital pharmaceutical supply chain using globally accepted GS1 standards.

Key focus areas include:

  • Product serialization

  • GS1 DataMatrix implementation

  • Product verification

  • Supply chain traceability

  • Digital reporting

  • Anti-counterfeiting protection

This regulation represents the final phase of Pakistan's pharmaceutical digital transformation.

GS1 Standards Required for Compliance

Pakistan's pharmaceutical track and trace system is based on internationally recognized GS1 standards.

Manufacturers are expected to implement:

GTIN (Global Trade Item Number)

Each pharmaceutical product receives a globally unique identification number.

GS1 DataMatrix Barcode

The two-dimensional barcode stores critical product information, including:

  • GTIN

  • Serial Number

  • Batch Number

  • Expiry Date

Serialization

Every saleable unit receives a unique serial number that cannot be duplicated.

SSCC (Serial Shipping Container Code)

Logistics units such as cartons and pallets are identified using globally unique shipping codes.

Benefits of the Pakistan Track & Trace System

Implementation offers significant advantages for manufacturers, regulators, healthcare providers, and patients.

Improved Patient Safety

Patients can verify medicine authenticity before use.

Counterfeit Prevention

Unique serialization makes product duplication significantly more difficult.

Supply Chain Visibility

Manufacturers can monitor products throughout distribution.

Faster Product Recalls

Defective batches can be located quickly and removed from the market.

Export Readiness

Compliance with GS1 standards helps manufacturers meet international regulatory requirements.

Regulatory Compliance

Companies remain aligned with DRAP regulations while preparing for future digital healthcare initiatives.

Challenges Facing Pharmaceutical Manufacturers

Despite its benefits, implementation presents several challenges.

These include:

  • Investment in serialization equipment

  • Software integration

  • Packaging line upgrades

  • Data management

  • Employee training

  • Warehouse aggregation

  • Regulatory reporting

  • ERP integration

Small and medium-sized manufacturers may require additional technical support during implementation.

How Pharmaceutical Companies Can Prepare

To ensure successful compliance, companies should begin preparations early.

Recommended steps include:

  1. Conduct a serialization readiness assessment.

  2. Upgrade packaging lines.

  3. Implement GS1-compliant barcode printing.

  4. Deploy serialization software.

  5. Integrate ERP systems.

  6. Validate production processes.

  7. Train operational teams.

  8. Perform pilot testing before full deployment.

Early implementation reduces operational disruptions and ensures smoother regulatory compliance.

Future of Pharmaceutical Traceability in Pakistan

Pakistan's pharmaceutical industry is moving toward complete digital traceability.

Future developments may include:

  • Real-time product verification

  • Mobile authentication applications

  • AI-powered counterfeit detection

  • Blockchain-enabled supply chains

  • Enhanced export compliance

  • Greater integration with healthcare systems

These technologies will further strengthen medicine safety and improve public confidence in pharmaceutical products.

Conclusion

The Pakistan Pharmaceutical Track & Trace System marks a significant milestone in the country's pharmaceutical regulatory landscape. Through GS1-based serialization, barcode implementation, and digital traceability, DRAP aims to create a safer, more transparent, and globally competitive pharmaceutical supply chain.

The introduction of S.R.O. 963(I)/2026 provides the final regulatory framework for manufacturers to modernize operations and comply with international best practices.

Organizations that invest early in serialization technology, software integration, and supply chain digitalization will be well positioned for long-term regulatory compliance and business growth.

Frequently Asked Questions (FAQs)
What is the Pakistan Pharmaceutical Track & Trace System?

It is a national serialization system introduced by DRAP to identify and trace pharmaceutical products throughout the supply chain.

What is S.R.O. 963(I)/2026?

It is the latest DRAP regulation published on 9 June 2026 that finalizes Pakistan's pharmaceutical track and trace requirements.

Which barcode is required?

Manufacturers must use the GS1 DataMatrix barcode on secondary packaging.

Is serialization mandatory in Pakistan?

Yes. Pharmaceutical manufacturers are required to implement serialization according to DRAP regulations.

Why is pharmaceutical serialization important?

Serialization helps prevent counterfeit medicines, improves patient safety, enables efficient product recalls, and enhances supply chain transparency.

Pakistan Pharmaceutical Track & Trace System 2026: New DRAP Regulations and Industry Impact

MedRASm

Medical Regulatory Affairs & Systems Management

Contact

Subscribe

info@medrasm.com

+92 335 9000 267

© 2018 - 2026 All rights reserved